دورية أكاديمية

Changes in intestinal bacteria and imbalances of metabolites induced in the intestines of pancreatic ductal adenocarcinoma patients in a Japanese population: a preliminary result.

التفاصيل البيبلوغرافية
العنوان: Changes in intestinal bacteria and imbalances of metabolites induced in the intestines of pancreatic ductal adenocarcinoma patients in a Japanese population: a preliminary result.
المؤلفون: Hashimoto, Senju, Tochio, Takumi, Funasaka, Kohei, Funahashi, Kazuki, Hartanto, Tenagy, Togashi, Yuka, Saito, Misa, Nishimoto, Yuichiro, Yoshinori, Mizuguchi, Nakaoka, Kazunori, Watanabe, Ayako, Nagasaka, Mitsuo, Nakagawa, Yoshihito, Miyahara, Ryoji, Shibata, Tomoyuki, Hirooka, Yoshiki
المصدر: Scandinavian Journal of Gastroenterology; Feb2023, Vol. 58 Issue 2, p193-198, 6p
مصطلحات موضوعية: PANCREATIC duct, JAPANESE people, INTESTINES, METABOLITES, STREPTOCOCCUS, DEOXYCHOLIC acid
مستخلص: The relationship between pancreatic ductal adenocarcinoma (PDAC) and the intestinal environment is not fully understood. The purpose of this study was to elucidate the characteristics of the intestinal environment in PDAC. We performed a case-control study of 5 Japanese patients with unresectable PDAC located in the body or tail (PDAC-bt). The number of patients analyzed was limited for this preliminary study. We included 68 healthy subjects, herein control, of pre-printed study in the preliminary study. 16S rRNA amplicon sequencing and metabolomic analysis were performed using fecal samples from the subjects. There was no difference in the Shannon index and Principal Coordinate Analysis between PDAC-bt and the control. However, a significant increase in oral-associated bacteria (Actinomyces, Streptococcus, Veillonella, Lactobacillus) was observed. A significant decrease of Anaerostipes was demonstrated in the feces of PDAC-bt compared with the control. The intestinal propionic acid and deoxycholic acid were significantly lower in PDAC-bt compared with the control. We showed that the intestinal environment of PDAC-bt is characterized by an increase in oral-associated bacteria and an imbalance of metabolites but without changes in alpha and beta diversity of the gut microbiota profiles. Clinical Trial Registration: , UMIN 000041974, 000023675, 000023970. [ABSTRACT FROM AUTHOR]
Copyright of Scandinavian Journal of Gastroenterology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00365521
DOI:10.1080/00365521.2022.2114812